Previous close | 18.73 |
Open | 17.10 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's range | 17.10 - 17.10 |
52-week range | 17.10 - 17.10 |
Volume | |
Avg. volume | N/A |
Market cap | N/A |
Beta (5Y monthly) | 1.08 |
PE ratio (TTM) | 24.23 |
EPS (TTM) | 1.00 |
Earnings date | 03 Aug 2022 - 08 Aug 2022 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
While XOMA Corporation ( NASDAQ:XOMA ) shareholders are probably generally happy, the stock hasn't had particularly...
Ad-hoc announcement pursuant to Article 53 of the SIX listing rules • $2.5 million of milestone to be paid to XOMA Corporation under royalty agreement SCHLIEREN (ZURICH), Switzerland, June 02, 2022 (GLOBE NEWSWIRE) -- Kuros Biosciences AG (“Kuros” or the “Company”), a leader in next generation bone graft technologies, notes the completion of the acquisition of Checkmate Pharmaceuticals (NASDAQ: CMPI) by Regeneron Pharmaceuticals (NASDAQ: REGN). The completion triggers a $5 million milestone paym
XOMA (NASDAQ:XOMA) has had a rough three months with its share price down 13%. But if you pay close attention, you...